MedPointe – Management 3

Mission Management Partnerships Sales & Marketing
Investors Board of Directors

Mark S. Spiers

Senior Vice President – Commercial Operations

Mark S. Spiers, Senior Vice President – Commercial Operations, has acquired substantial experience and established a strong track record in running a range of commercial pharmaceutical organizations.

From 2001 until Pfizer’s acquisition of Pharmacia earlier this year, he served as Pharmacia’s Group Vice President and President of North American Operations, responsible for leading the company’s $7.5 billion US and Canadian pharmaceuticals business with direct oversight of sales, sales operations, managed care, distribution, training, IT, and e-channel business. During this period, Mr. Spiers’ organization launched Bextra�, currently one of the top-selling anti-arthritis medications in the US. In addition, he re-designed Pharmacia’s field force and managed care organizations and contributed to major changes in the company’s training and marketing practices. Immediately prior, Mr. Spiers was Pharmacia’s Group Vice President for Corporate Operations (2000-2001) and Group Vice President for US Operations (1999-2000) at Pharmacia & Upjohn, where he led a $3.5 billion US pharmaceuticals business.

Mr. Spiers began his pharmaceuticals career in 1975 at Bristol-Myers Squibb Company (BMS) as a Dallas, TX-based sales representative. He was promoted at BMS through a succession of progressively senior sales, marketing, and sales management positions from 1975-1999. Mr. Spiers was named Vice President of Sales at BMS in 1991, and in 1993, he went on to lead BMS’s Managed Care organization. In 1996, he moved to the BMS international organization and assumed responsibility for its Intercontinental marketing group for Anti-Infectives, Cardiovascular, CNS, and Oncology. In his last position with the company, he ran BMS’s tenth largest business unit as General Manager of Australia/New Zealand from 1997-1999.

Mr. Spiers is a former member of the Board of the National Pharmaceutical Council and the Australian Pharmaceutical Manufacturers Association.
He is a graduate of Austin College, Sherman, TX.